According to our (Global Info Research) latest study, the global Coronary Artery Bypass Grafts (CABG) market size was valued at US$ 153 million in 2025 and is forecast to a readjusted size of US$ 216 million by 2032 with a CAGR of 5.1% during review period.
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Coronary artery bypass grafting (CABG) is a surgical intervention to restore myocardial blood supply by creating bypass conduits—using autologous or alternative vascular grafts—around narrowed or occluded coronary arteries to preserve cardiac muscle, relieve ischemic symptoms, and reduce the risk of adverse cardiac events. As a standard of care for multivessel and complex coronary disease, CABG spans from conventional open-chest on-pump procedures to refined, less invasive techniques and supporting adjuncts. The perioperative ecosystem—graft preservation, intraoperative perfusion management, hemostasis, consumables, and postoperative rehabilitation—forms an integrated market that includes devices, disposables, pharmacologic adjuncts, and service offerings.
The sustained public-health emphasis on cardiovascular disease burden provides an enduring demand base for CABG where durable outcomes and long-term quality of life matter. Innovations in graft preservation, intraoperative blood management and alternative conduit materials, together with commercialization by listed and R&D companies, are expanding addressable product categories and creating premium commercialization opportunities for firms that can pair clinical evidence with scalable manufacturing.
Major restraints include rigid regulatory requirements, the need for long-term clinical evidence, and stringent quality controls. Novel devices and graft materials typically require extended clinical programs and regulatory interactions before adoption into standard surgical pathways; post-market safety or quality issues can materially impact compliance costs and brand trust. Supply-chain robustness, sterile manufacturing capability, and hospital budget dynamics also present tangible commercialization risks.
This report is a detailed and comprehensive analysis for global Coronary Artery Bypass Grafts (CABG) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Coronary Artery Bypass Grafts (CABG) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Coronary Artery Bypass Grafts (CABG) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Coronary Artery Bypass Grafts (CABG) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Coronary Artery Bypass Grafts (CABG) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coronary Artery Bypass Grafts (CABG)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Coronary Artery Bypass Grafts (CABG) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical, Karl Storz GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Coronary Artery Bypass Grafts (CABG) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other
Market segment by Application
Traditional CABG
Nontraditional CABG
Market segment by players, this report covers
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Coronary Artery Bypass Grafts (CABG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Coronary Artery Bypass Grafts (CABG), with revenue, gross margin, and global market share of Coronary Artery Bypass Grafts (CABG) from 2021 to 2026.
Chapter 3, the Coronary Artery Bypass Grafts (CABG) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Coronary Artery Bypass Grafts (CABG) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Coronary Artery Bypass Grafts (CABG).
Chapter 13, to describe Coronary Artery Bypass Grafts (CABG) research findings and conclusion.
Summary:
Get latest Market Research Reports on Coronary Artery Bypass Grafts (CABG). Industry analysis & Market Report on Coronary Artery Bypass Grafts (CABG) is a syndicated market report, published as Global Coronary Artery Bypass Grafts (CABG) Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Coronary Artery Bypass Grafts (CABG) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.